PetMed (PETS) delivered earnings and revenue surprises of -46.15% and 13.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Two Pet Health Stocks To Watch And One To Avoid

04:00am, Tuesday, 05'th Jul 2022
Growth stocks have been getting pummeled this year due to fears of slowing growth, tightening margins, and recession but in some cases, the baby is getting tossed out with the bathwater. In this case,
PetMed Express, Inc. (NASDAQ:PETS) is an online pet pharmacy based in the U.S. that is licensed to dispense prescription medications in all 50 states.
As the stock market plunges toward bear market territory, investors increasingly look for dividend stocks to buy. These are the best dividend stocks to buy now.
We analyzed its AutoShip & Save program which was introduced in 2021 and expect it to contribute to higher recurring revenue with higher reorder sales as a percentage of revenue. Additionally, we beli
PetMed Express Inc. PETS, +6.44% says its fiscal fourth-quarter sales suffered from a slow start to the flea-and-tick season, but the company expects that part of the business to bounce back as the wa
Shares of PetMeds (NASDAQ: PETS) are rocketing higher in the wake of what we can only call a mixed report. The news wasn't bad and it wasn't good and it certainly isn't enough to have shares up by 9%,
Petmed Express, Inc. (NASDAQ:PETS ) Q4 2021 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Bruce Rosenbloom - CFO & Treasurer Matthew Hulett - CEO, President & Director Conferenc

PetMed (PETS) Q4 Earnings Top Estimates

06:48pm, Monday, 09'th May 2022
PetMed (PETS) delivered earnings and revenue surprises of 11.11% and 2.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
DELRAY BEACH, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter and year ended March 31, 2022, on Monday, May 9, 2022, at 4
PetMed Express Inc (NASDAQ: PETS) reported a Q3 EPS of $0.21, missing the consensus of $0.33 and lower than $0.38 posted a year ago. Net sales were $60.7 million, down 7.9% Y/Y and far below the con
PetMed Express, Inc. (PETS) CEO Matt Hulett on Q3 2021 Results - Earnings Call Transcript
Shares of PetMed Express are down more than 3% in after-hours trading after the pet medicines company fiscal third quarter results missed on both EPS and revenue.
PetMed Express press release (NASDAQ:PETS): FQ3 GAAP EPS of $0.21 misses by $0.08.Revenue of $60.72M (-7.9% Y/Y) misses by $3.39M.Shares -11.13%.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE